Skip Navigation
Skip to contents

JMD : Journal of Movement Disorders

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Marie Vidailhet 1 Article
Oromandibular Dystonia: Demographics and Clinical Data from 240 Patients
Linda Slaim, Myriam Cohen, Patrick Klap, Marie Vidailhet, Alain Perrin, Daniel Brasnu, Denis Ayache, Marie Mailly
J Mov Disord. 2018;11(2):78-81.   Published online May 30, 2018
DOI: https://doi.org/10.14802/jmd.17065
  • 7,673 View
  • 231 Download
  • 23 Web of Science
  • 27 Crossref
AbstractAbstract PDF
Objective
To report demographic data from a large cohort of patients with oromandibular dystonia (OMD).
Methods
This is a retrospective review of patients with OMD referred to our institution between 1989 and 2015. Demographic (age of onset, gender, and familial history of dystonia) and clinical (type of OMD, associated dystonia, and etiology of dystonia) data were collected from a cohort of 240 individuals.
Results
The mean age of onset of OMD was 51.6 years old, with a female predominance (2:1). A family history of dystonia was found in 6 patients (2.5%). One hundred and forty-nine patients (62.1%) had the jaw-opening type of OMD, 48 patients (20.0%) had the jaw-closing type, and 43 patients (17.9%) had a mixed form of OMD. Lingual dystonia was also present in 64 (26.7%) of these patients. Eighty-two patients (34.2%) had a focal dystonia, 131 patients (54.6%) had a segmental dystonia, and 27 patients (11.3%) had a generalized dystonia. One hundred and seventy-one patients (71.3%) had idiopathic OMD.
Conclusion
OMD is a chronic and disabling focal dystonia. Our study found a prevalence of female patients, an onset in middle age and a predominantly idiopathic etiology. Unlike other studies, jaw-opening was found to be the most frequent clinical type of OMD.

Citations

Citations to this article as recorded by  
  • Surface electromyography for evaluating patients with oromandibular dystonia
    Jae-Hyung Kim, Byung-Gook Kim, Yeong-Gwan Im
    CRANIO®.2024; 42(3): 316.     CrossRef
  • Tongue dystonia as CIS and presenting symptom of multiple sclerosis
    Farid Shamlou, Narges Ebrahimi, Ahmad Chitsaz
    Neuroimmunology Reports.2024; 5: 100191.     CrossRef
  • Oromandibular dystonia: from onset to spread a multicenter italian study
    Assunta Trinchillo, Marcello Esposito, Carmen Terranova, Vincenzo Rizzo, Giovanni Fabbrini, Gina Ferrazzano, Daniele Belvisi, Roberto Erro, Paolo Barone, Francesco Bono, Francesca Di Biasio, Anna Rita Bentivoglio, Christian Lettieri, Maria Concetta Altavi
    Neurological Sciences.2024; 45(9): 4341.     CrossRef
  • A Case Study of Korean Medicine Treatment in a Patient Complaining of Generalized Dystonia
    Kyeong-hwa Lee, Hye-min Heo, Dong-joo Kim, Min-jae Kwak, Ye-chae Hwang, Seung-yeon Cho, Jung-mi Park, Chang-nam Ko, Seong-uk Park
    The Journal of Internal Korean Medicine.2024; 45(2): 208.     CrossRef
  • Oromandibular Dystonia: Clinical and Demographic Data from Eight-Two Patients
    Mehmet Balal, Meltem Demirkiran
    Tremor and Other Hyperkinetic Movements.2023;[Epub]     CrossRef
  • Oromandibular Dystonia is a Prominent Feature in Patients with Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Helio van der Linden Jr., Christiane Cobas, Andre Felipe Pinto Duarte, Marcelo Rodrigues Masruha
    Journal of Inborn Errors of Metabolism and Screening.2023;[Epub]     CrossRef
  • Clinical Presentation and Management of Peripheral-induced Oromandibular Dystonia in Nigeria: A Case Report and Literature Update
    Nonso Emmanuel Onyia, Mercy Okoh, Obinna Francis Igwilo, Izegboya Vivian Ukpebor, Eze Stephen Nwauzor
    Nigerian Journal of Medicine.2023; 32(4): 433.     CrossRef
  • Oromandibular Dystonia – A Systematic Review
    Udit Saraf, Mitesh Chandarana, K. P Divya, Syam Krishnan
    Annals of Indian Academy of Neurology.2022; 25(1): 26.     CrossRef
  • Botulinum Toxin Therapy for Oromandibular Dystonia and Other Movement Disorders in the Stomatognathic System
    Kazuya Yoshida
    Toxins.2022; 14(4): 282.     CrossRef
  • Botulinum toxin injections in jaw-opening dystonia. The lateral pterygoid – maxillary artery problem
    Sena Ünal, F. Tugra Karaarslan-Turk, Muhittin Cenk Akbostanci, Elif Peker, Rezzak Yilmaz
    Journal of Clinical Neuroscience.2022; 101: 217.     CrossRef
  • Oromandibular dystonia seen during pramipexole treatment: A rare case
    Fatma KARA, Mehmet Fatih GÖL, Ayhan VARLIBAŞ
    Journal of Surgery and Medicine.2022; 6(6): 1.     CrossRef
  • Dystonia, chorea, hemiballismus and other dyskinesias
    Matteo Bologna, Josep Valls-Solè, Nitish Kamble, Pramod Kumar Pal, Antonella Conte, Andrea Guerra, Daniele Belvisi, Alfredo Berardelli
    Clinical Neurophysiology.2022; 140: 110.     CrossRef
  • Movement disorders of the mouth: a review of the common phenomenologies
    C. M. Ghadery, L. V. Kalia, B. S. Connolly
    Journal of Neurology.2022; 269(11): 5812.     CrossRef
  • Botulinum Toxin in Movement Disorders: An Update
    Charenya Anandan, Joseph Jankovic
    Toxins.2021; 13(1): 42.     CrossRef
  • Temporomandibular disorder–related characteristics and treatment outcomes in Oromandibular Dystonia patients in two different clinical settings: A cross‐sectional study
    Asha Sude, Joseph Matsumoto, Shanti Kaimal, Ashley Petersen, Donald R. Nixdorf
    Journal of Oral Rehabilitation.2021; 48(5): 542.     CrossRef
  • Jaw Pain and Oromandibular Dysfunction After a Complex Hospital Course
    Sarah Smith, Ny-Ying Lam
    American Journal of Physical Medicine & Rehabilitation.2021; 100(5): e62.     CrossRef
  • Oromandibular Dystonia: A Clinical Examination of 2,020 Cases
    Laura M. Scorr, Stewart A. Factor, Sahyli Perez Parra, Rachel Kaye, Randal C. Paniello, Scott A. Norris, Joel S. Perlmutter, Tobias Bäumer, Tatiana Usnich, Brian D. Berman, Marie Mailly, Emmanuel Roze, Marie Vidailhet, Joseph Jankovic, Mark S. LeDoux, Ric
    Frontiers in Neurology.2021;[Epub]     CrossRef
  • Evaluation of Treatment Outcomes in Oromandibular Dystonia Using Surface Electromyography: A Case Series
    Yeong-Gwan Im, Jae-Hyung Kim, Byung-Gook Kim
    Journal of Oral Medicine and Pain.2021; 46(4): 143.     CrossRef
  • Application of botulinum toxin in pregnancy and its impact on female reproductive health
    Wu Li, Min Tang
    Expert Opinion on Drug Safety.2020; 19(1): 83.     CrossRef
  • Prevalence and clinical characteristics of patients with oromandibular dystonia seen in the orofacial pain clinic: a retrospective study
    Asha Sude, Donald R. Nixdorf
    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology.2020; 130(2): 169.     CrossRef
  • Clinical spectrum of focal dystonias: Experience from a tertiary care center
    Rupesh Prasad, Deepika Joshi, VijayN Mishra, RameshwarN Chaurasia, Abhishek Pathak
    Annals of Movement Disorders.2020; 3(2): 99.     CrossRef
  • Bite injury related to oromandibular dystonia extending to the maxillary sinus: A case report
    Yoshiro Koma, Takehiro Fujimoto, Shinji Uejima, Kotaro Sato, Keisuke Sugimoto, Satoshi Yamaguchi, Jun Ishikawa, Kazuya Nambu, Hideharu Hibi
    Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology.2020; 32(6): 503.     CrossRef
  • Botulinum neurotoxin a therapy efficacy and safety for oromandibular dystonia: a meta-analysis
    Pariessa D. Dadgardoust, Raymond L. Rosales, Ria Monica Asuncion, Dirk Dressler
    Journal of Neural Transmission.2019; 126(2): 141.     CrossRef
  • Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features
    Kazuya Yoshida
    Toxins.2019; 11(1): 51.     CrossRef
  • Oromandibular dystonia, mental distress and oro‐facial dysfunction—A follow‐up 8‐10 years after start of treatment with botulinum toxin
    Merete Bakke, Sara Baram, Torben Dalager, Heidi Bryde Biernat, Eigild Møller
    Journal of Oral Rehabilitation.2019; 46(5): 441.     CrossRef
  • Pseudodystonia: A new perspective on an old phenomenon
    Rok Berlot, Kailash P. Bhatia, Maja Kojović
    Parkinsonism & Related Disorders.2019; 62: 44.     CrossRef
  • Severe Jaw‐Opening Dystonia as an Unusual Manifestation of Levodopa‐Related Wearing‐Off in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection
    Pankaj Ashok Agarwal
    Movement Disorders Clinical Practice.2019; 6(6): 500.     CrossRef

JMD : Journal of Movement Disorders Twitter
Close layer
TOP